Patient characteristics for the paediatric DAH cohort and the total ARISE Registry cohort (all DAH)
. | Paediatric AVR, n = 143 . | All DAH n = 358 . |
---|---|---|
Implantation period | 2008–2023 | 2008–2023 |
Age at implantation (years) | 10.8 [6.6–14.6] | 23.9 [12.5–44.8] |
Follow-up (years) | 5.3 [3.3–7.2] | 5.0 [3.1–6.5] |
Total follow-up (years) | 756 | 1748 |
Sex (male) | 106 (74%) | 250 (70 %) |
Number of previous operations | ||
0 | 59 | 200 |
1 | 47 | 90 |
2 | 24 | 46 |
>2 | 13 | 22 |
Type of previous procedures | ||
1 × aortic valve replacement | 19 | 49 |
2 × aortic valve replacement | 4 | 11 |
3 × aortic valve replacement | 1 | 2 |
Catheter-based intervention | 68 | 92 |
Aortic valve repair | 28 | 40 |
Allograft diameter (mm), median [IQR] | 21 [19–23] | 23 [21–25] |
10–18 | 26 | 28 |
19–22 | 76 | 127 |
23–29 | 41 | 203 |
Implantation time (min) | ||
Total operation | 348 [227–439] | 303 [244–400] |
Cardiopulmonary bypass | 212 [171–257] | 168 [132–220] |
Cross clamp | 135 [113–164] | 120 [97–146] |
Latest echocardiography | ||
Aortic annulus (mm) | 20.5 (3.7) | 22.1 (3.8) |
Aortic annulus, z-score | 0.02(1.50) | 0.18 (1.47) |
Effective orifice area (cm2) | 2.36 (0.84) | 2.95 (0.83) |
Peak gradient (mmHg) | 14 [9–28] | 11.6 [7.8–19.4] |
Regurgitation (grade 0–3) | 0.5 [0–1] | 0.5 [0–1] |
LV ejection fraction (%) | 64.7 [58.5–68.5] | 64.0 [59.5–68.0] |
. | Paediatric AVR, n = 143 . | All DAH n = 358 . |
---|---|---|
Implantation period | 2008–2023 | 2008–2023 |
Age at implantation (years) | 10.8 [6.6–14.6] | 23.9 [12.5–44.8] |
Follow-up (years) | 5.3 [3.3–7.2] | 5.0 [3.1–6.5] |
Total follow-up (years) | 756 | 1748 |
Sex (male) | 106 (74%) | 250 (70 %) |
Number of previous operations | ||
0 | 59 | 200 |
1 | 47 | 90 |
2 | 24 | 46 |
>2 | 13 | 22 |
Type of previous procedures | ||
1 × aortic valve replacement | 19 | 49 |
2 × aortic valve replacement | 4 | 11 |
3 × aortic valve replacement | 1 | 2 |
Catheter-based intervention | 68 | 92 |
Aortic valve repair | 28 | 40 |
Allograft diameter (mm), median [IQR] | 21 [19–23] | 23 [21–25] |
10–18 | 26 | 28 |
19–22 | 76 | 127 |
23–29 | 41 | 203 |
Implantation time (min) | ||
Total operation | 348 [227–439] | 303 [244–400] |
Cardiopulmonary bypass | 212 [171–257] | 168 [132–220] |
Cross clamp | 135 [113–164] | 120 [97–146] |
Latest echocardiography | ||
Aortic annulus (mm) | 20.5 (3.7) | 22.1 (3.8) |
Aortic annulus, z-score | 0.02(1.50) | 0.18 (1.47) |
Effective orifice area (cm2) | 2.36 (0.84) | 2.95 (0.83) |
Peak gradient (mmHg) | 14 [9–28] | 11.6 [7.8–19.4] |
Regurgitation (grade 0–3) | 0.5 [0–1] | 0.5 [0–1] |
LV ejection fraction (%) | 64.7 [58.5–68.5] | 64.0 [59.5–68.0] |
Mean and standard deviation are shown in round brackets for normally distributed factors, median and IQR are shown in square brackets for factors with no normal distribution.
AVR: aortic valve replacement; DAH: decellularized aortic homografts; IQR: interquartile range; LV: left ventricular.
Patient characteristics for the paediatric DAH cohort and the total ARISE Registry cohort (all DAH)
. | Paediatric AVR, n = 143 . | All DAH n = 358 . |
---|---|---|
Implantation period | 2008–2023 | 2008–2023 |
Age at implantation (years) | 10.8 [6.6–14.6] | 23.9 [12.5–44.8] |
Follow-up (years) | 5.3 [3.3–7.2] | 5.0 [3.1–6.5] |
Total follow-up (years) | 756 | 1748 |
Sex (male) | 106 (74%) | 250 (70 %) |
Number of previous operations | ||
0 | 59 | 200 |
1 | 47 | 90 |
2 | 24 | 46 |
>2 | 13 | 22 |
Type of previous procedures | ||
1 × aortic valve replacement | 19 | 49 |
2 × aortic valve replacement | 4 | 11 |
3 × aortic valve replacement | 1 | 2 |
Catheter-based intervention | 68 | 92 |
Aortic valve repair | 28 | 40 |
Allograft diameter (mm), median [IQR] | 21 [19–23] | 23 [21–25] |
10–18 | 26 | 28 |
19–22 | 76 | 127 |
23–29 | 41 | 203 |
Implantation time (min) | ||
Total operation | 348 [227–439] | 303 [244–400] |
Cardiopulmonary bypass | 212 [171–257] | 168 [132–220] |
Cross clamp | 135 [113–164] | 120 [97–146] |
Latest echocardiography | ||
Aortic annulus (mm) | 20.5 (3.7) | 22.1 (3.8) |
Aortic annulus, z-score | 0.02(1.50) | 0.18 (1.47) |
Effective orifice area (cm2) | 2.36 (0.84) | 2.95 (0.83) |
Peak gradient (mmHg) | 14 [9–28] | 11.6 [7.8–19.4] |
Regurgitation (grade 0–3) | 0.5 [0–1] | 0.5 [0–1] |
LV ejection fraction (%) | 64.7 [58.5–68.5] | 64.0 [59.5–68.0] |
. | Paediatric AVR, n = 143 . | All DAH n = 358 . |
---|---|---|
Implantation period | 2008–2023 | 2008–2023 |
Age at implantation (years) | 10.8 [6.6–14.6] | 23.9 [12.5–44.8] |
Follow-up (years) | 5.3 [3.3–7.2] | 5.0 [3.1–6.5] |
Total follow-up (years) | 756 | 1748 |
Sex (male) | 106 (74%) | 250 (70 %) |
Number of previous operations | ||
0 | 59 | 200 |
1 | 47 | 90 |
2 | 24 | 46 |
>2 | 13 | 22 |
Type of previous procedures | ||
1 × aortic valve replacement | 19 | 49 |
2 × aortic valve replacement | 4 | 11 |
3 × aortic valve replacement | 1 | 2 |
Catheter-based intervention | 68 | 92 |
Aortic valve repair | 28 | 40 |
Allograft diameter (mm), median [IQR] | 21 [19–23] | 23 [21–25] |
10–18 | 26 | 28 |
19–22 | 76 | 127 |
23–29 | 41 | 203 |
Implantation time (min) | ||
Total operation | 348 [227–439] | 303 [244–400] |
Cardiopulmonary bypass | 212 [171–257] | 168 [132–220] |
Cross clamp | 135 [113–164] | 120 [97–146] |
Latest echocardiography | ||
Aortic annulus (mm) | 20.5 (3.7) | 22.1 (3.8) |
Aortic annulus, z-score | 0.02(1.50) | 0.18 (1.47) |
Effective orifice area (cm2) | 2.36 (0.84) | 2.95 (0.83) |
Peak gradient (mmHg) | 14 [9–28] | 11.6 [7.8–19.4] |
Regurgitation (grade 0–3) | 0.5 [0–1] | 0.5 [0–1] |
LV ejection fraction (%) | 64.7 [58.5–68.5] | 64.0 [59.5–68.0] |
Mean and standard deviation are shown in round brackets for normally distributed factors, median and IQR are shown in square brackets for factors with no normal distribution.
AVR: aortic valve replacement; DAH: decellularized aortic homografts; IQR: interquartile range; LV: left ventricular.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.